The gut microbiome and dietary metabolites in the treatment of renal cell carcinoma

Authors: Zugman, Miguel ^{a, b}, Wong, Megan ^a, Jaime-Casas, Salvador ^a, Pal, Sumanta K. ^{a, ⁎}

Source: In Urologic Oncology: Seminars and Original Investigations April 2025 43(4):244-253

First-line Systemic Therapy Following Adjuvant Immunotherapy in Renal Cell Carcinoma: An International Multicenter Study

Authors: El Zarif, Talal, Semaan, Karl, Xie, Wanling, Eid, Marc, Zarba, Martin, Issa, Wadih, Zhang, Tian, Nguyen, Charles B., Alva, Ajjai, Fahey, Catherine C., Beckermann, Kathryn E., Karam, Jose A., Campbell, Matthew T., Procopio, Giuseppe, Stellato, Marco, Buti, Sebastiano, Zemankova, Anezka, Melichar, Bohuslav, Massari, Francesco, Mollica, Veronica, Venugopal, Balaji, Ebrahimi, Hedyeh, de Velasco, Guillermo, Gurney, Howard Paul, De Giorgi, Ugo, Parikh, Omi, Winquist, Eric, Master, Viraj, Garcia, Abraham Ruiz, Cutuli, Hernan Javier, Ferguson, Thomas Robert, Gross-Goupil, Marine, Baca, Sylvan C., Pal, Sumanta K., Braun, David A., McKay, Rana R., Heng, Daniel Y.C., Choueiri, Toni K.

Source: In European Urology December 2024 86(6):503-512

Impact of Synchronous versus Metachronous Metastasis on Outcomes in Patients with Metastatic Renal Cell Carcinoma Treated with First-line Immune Checkpoint Inhibitor–based Combinations

Authors: Gebrael, Georges ^{a, †}, Meza, Luis ^{b, d, †}, Li, Xiaochen ^b, Zengin, Zeynep ^{b, d}, Sayegh, Nicolas ^{a, e}, Ebrahimi, Hedyeh ^b, Tripathi, Nishita ^a, Castro, Daniela ^b, Mercier, Benjamin ^b, Barragan-Carrillo, Regina ^b, Li, Haoran ^c, Chehrazi-Raffle, Alexander ^b, Swami, Umang ^a, Tripathi, Abhishek ^b, Agarwal, Neeraj ^a, Maughan, Benjamin L. ^{a, ⁎}, Pal, Sumanta K. ^{b, ⁎}

Source: In European Urology Focus September 2024 10(5):812-817

Adjuvant Everolimus in Patients with Completely Resected, Very High-risk Renal Cell Carcinoma of Clear Cell Histology: Results from the Phase 3 Placebo-controlled SWOG S0931 (EVEREST) Trial

Authors: Lara, Primo N., Jr, Tangen, Catherine, Heath, Elisabeth I., Gulati, Shuchi, Stein, Mark N., Meng, Maxwell, Alva, Ajjai Shivaram, Pal, Sumanta K., Puzanov, Igor, Clark, Joseph I., Choueiri, Toni K., Agarwal, Neeraj, Uzzo, Robert, Haas, Naomi B., Synold, Timothy W., Plets, Melissa, Vaishampayan, Ulka N., Shuch, Brian M., Lerner, Seth, Thompson, Ian M., Jr, Ryan, Christopher W.

Source: In European Urology September 2024 86(3):258-264

Characterization of Patients with Metastatic Renal Cell Carcinoma Undergoing Deferred, Upfront, or No Cytoreductive Nephrectomy in the Era of Combination Immunotherapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium

Authors: Takemura, Kosuke, Ernst, Matthew S., Navani, Vishal, Wells, J. Connor, Bakouny, Ziad, Donskov, Frede, Basappa, Naveen S., Wood, Lori A., Meza, Luis, Pal, Sumanta K., Szabados, Bernadett, Powles, Thomas, Beuselinck, Benoit, McKay, Rana R., Lee, Jae-Lyun, Ernst, D. Scott, Kapoor, Anil, Yuasa, Takeshi, Choueiri, Toni K., Heng, Daniel Y.C.

Source: In European Urology Oncology June 2024 7(3):501-508

Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination Therapies for Metastatic Renal Cell Carcinoma

Authors: Ernst, Matthew S., Navani, Vishal, Wells, J. Connor, Donskov, Frede, Basappa, Naveen, Labaki, Chris, Pal, Sumanta K., Meza, Luis, Wood, Lori A., Ernst, D. Scott, Szabados, Bernadett, McKay, Rana R., Parnis, Francis, Suarez, Cristina, Yuasa, Takeshi, Lalani, Aly-Khan, Alva, Ajjai, Bjarnason, Georg A., Choueiri, Toni K., Heng, Daniel Y.C.

Source: European urology. 84(1):109-116

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100193413531.0x000001&indx=1&recIds=ETOCvdc_100193413531.0x000001

Cardiovascular profile of contemporary treatments of renal cell carcinoma: A single-center prospective study

Authors: Lee, Kyuwan, Lindenfeld, Lanie, Echevarria, Meagan, Hsu, JoAnn, Wong, F. Lennie, Narayan, Hari K., Lau, Clayton, Cai, LiYing, Pal, Sumanta K., Armenian, Saro H., Rhee, June-Wha

Source: International journal of cardiology. 380:40-46

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100189691835.0x000001&indx=1&recIds=ETOCvdc_100189691835.0x000001

Genomic and Clinical Prognostic Factors in Patients With Advanced Urothelial Carcinoma Receiving Immune Checkpoint Inhibitors

Authors: Chawla, Neal S., Sayegh, Nicolas, Tripathi, Nishita, Govindarajan, Ameish, Zengin, Zeynep B., Phillip, Errol J., Dizman, Nazli, Meza, Luis, Muddasani, Ramya, Chehrazi-Raffle, Alexander, Malhotra, Jasnoor, Hsu, JoAnn, Agarwal, Neeraj, Pal, Sumanta K., Tripathi, Abhishek

Source: Clinical genitourinary cancer. 21(1):69-75

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100180136388.0x000001&indx=1&recIds=ETOCvdc_100180136388.0x000001

Perceptions of COVID-19 Vaccination in Patients with Genitourinary Cancers: A Survey Study

Authors: Castro, Daniela V., Zengin, Zeynep B., Malhotra, Jasnoor, Bergerot, Cristiane D., Meza, Luis, Dizman, Nazli, Govindarajan, Ameish, Hsu, JoAnn, Chehrazi-Raffle, Alex, Chawla, Neal, Mercier, Benjamin D., Chen, Sean W., Feng, Matthew, Prajapati, Sweta, Lee, Kyle O., Philip, Errol J., Dorff, Tanya B., Lyou, Yung, Pal, Sumanta K.

Source: Cancer investigation. 41(1):70-76

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100172139647.0x000001&indx=1&recIds=ETOCvdc_100172139647.0x000001

Examining Exclusion Criteria in Advanced Prostate Cancer Clinical Trials: An Assessment of recommendations From the American Society Of Clinical Oncology and Friends of Cancer Research

Authors: Ebrahimi, Hedyeh, Castro, Daniela V., Feng, Matthew I., Prajapati, Sweta R., Lee, Kyle O., Chan, Elyse H., Paul, Trishita, Sehgal, Ishaan, Patel, Jalen, Li, Xiaochan, Zengin, Zeynep B., Meza, Luis, Mercier, Benjamin D., Hsu, JoAnn, Govindarajan, Ameish, Chawla, Neal, Dizman, Nazli, Bergerot, Cristiane D., Rock, Adam, Liu, Sandy, Tripathi, Abhishek, Dorff, Tanya, Pal, Sumanta K., Chehrazi-Raffle, Alexander

Source: In Clinical Genitourinary Cancer December 2023 21(6):e467-e473

Association Between Time-of-Day of Immune Checkpoint Blockade Administration and Outcomes in Metastatic Renal Cell Carcinoma

Authors: Dizman, Nazli, Govindarajan, Ameish, Zengin, Zeynep B., Meza, Luis, Tripathi, Nishita, Sayegh, Nicolas, Castro, Daniela V., Chan, Elyse H., Lee, Kyle O., Prajapati, Sweta, Feng, Matthew, Loo, Vivian, Pace, Makala, O'Brien, Shea, Bailey, Erin, Barragan-Carrillo, Regina, Chehrazi-Raffle, Alex, Hsu, JoAnn, Li, Xiaochen, Agarwal, Neeraj, Pal, Sumanta K.

Source: In Clinical Genitourinary Cancer October 2023 21(5):530-536

Managing Metastatic Renal Cell Carcinoma after Progression on Immunotherapy

Authors: Barragan-Carrillo, Regina, Govindarajan, Ameish, Rock, Adam, Sperandio, Rubens C., Pal, Sumanta K.

Source: In Hematology/Oncology Clinics of North America October 2023 37(5):965-976

Adjuvant everolimus after surgery for renal cell carcinoma (EVEREST): a double-blind, placebo-controlled, randomised, phase 3 trial

Authors: Ryan, Christopher W ^*, Tangen, Catherine M, Heath, Elisabeth I, Stein, Mark N, Meng, Maxwell V, Alva, Ajjai S, Pal, Sumanta K, Puzanov, Igor, Clark, Joseph I, Choueiri, Toni K, Agarwal, Neeraj, Uzzo, Robert G, Haas, Naomi B, Synold, Timothy W, Plets, Melissa, Vaishampayan, Ulka N, Shuch, Brian M, Thompson, Ian M, Jr, Lara, Primo N, Jr

Source: In The Lancet 23-29 September 2023 402(10407):1043-1051

Real-world Practice Patterns and Safety of Concurrent Radiotherapy and Cabozantinib in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium

Authors: Loo Gan, Chun, Huang, Jiaming, Pan, Elizabeth, Xie, Wanling, Schmidt, Andrew L., Labaki, Chris, Meza, Luis, Bouchard, Gabrielle, Li, Haoran, Jackson-Spence, Francesca, Sánchez-Ruiz, Carla, Powles, Thomas, Kumar, Shruti A., Weise, Nicole, Hall, William A., Rose, Brent S., Beuselinck, Benoit, Suarez, Cristina, Pal, Sumanta K., Choueiri, Toni K., Heng, Daniel Y.C., McKay, Rana R.

Source: In European Urology Oncology April 2023 6(2):204-211

Temporal Characteristics of Adverse Events of Tivozanib and Sorafenib in Previously Treated Kidney Cancer

Authors: Zengin, Zeynep B., Pal, Sumanta K., McDermott, David F., Escudier, Bernard, Hutson, Thomas E., Porta, Camillo, Verzoni, Elena, Atkins, Michael B., Kasturi, Vijay, Rini, Brian

Source: In Clinical Genitourinary Cancer December 2022 20(6):553-557

“Collecting duct carcinoma of the kidney: diagnosis and implications for management”

Authors: Cabanillas, Gerardo, Montoya-Cerrillo, Diego, Kryvenko, Oleksandr N., Pal, Sumanta K., Arias-Stella, Javier A., III

Source: In Urologic Oncology: Seminars and Original Investigations December 2022 40(12):525-536

Targeting FGFR3 alterations with adjuvant infigratinib in invasive urothelial carcinoma: the phase III PROOF 302 trial

Authors: Pal, Sumanta K, Somford, Diederik M, Grivas, Petros, Sridhar, Srikala S, Gupta, Shilpa, Bellmunt, Joaquim, Sonpavde, Guru, Fleming, Mark T, Lerner, Seth P, Loriot, Yohann, Hoffman-Censits, Jean, Valderrama, Begoña P, Andresen, Corina, Schnabel, Marco J, Cole, Suzanne, Daneshmand, Siamak

Source: Future oncology. 18(21):2599-2614

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100191695230.0x000001&indx=1&recIds=ETOCvdc_100191695230.0x000001

Cabozantinib plus immunotherapy combinations in metastatic renal cell and urothelial carcinoma

Authors: Meza, Luis, Malhotra, Jasnoor, Favorito, Crystal, Pal, Sumanta K

Source: Future oncology. 18(1):21-33

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100187765585.0x000001&indx=1&recIds=ETOCvdc_100187765585.0x000001

Assessing the Safety and Efficacy of Two Starting Doses of Lenvatinib Plus Everolimus in Patients with Renal Cell Carcinoma: A Randomized Phase 2 Trial

Authors: Pal, Sumanta K., Puente, Javier, Heng, Daniel Y.C., Glen, Hilary, Koralewski, Piotr, Stroyakovskiy, Daniil, Alekseev, Boris, Parnis, Francis, Castellano, Daniel, Ciuleanu, Tudor, Lee, Jae Lyun, Sunela, Kaisa, O'Hara, Karen, Binder, Terri A., Peng, Lixian, Smith, Alan D., Rha, Sun Young

Source: European urology. 82(3):283-292

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100168520366.0x000001&indx=1&recIds=ETOCvdc_100168520366.0x000001

A Prospective Multicenter Evaluation of Initial Treatment Choice in Metastatic Renal Cell Carcinoma Prior to the Immunotherapy Era: The MaRCC Registry Experience

Authors: Costello, Brian A., Bhavsar, Nrupen A., Zakharia, Yousef, Pal, Sumanta K., Vaishampayan, Ulka, Jim, Heather, Fishman, Mayer N., Molina, Ana M., Kyriakopoulos, Christos E., Tsao, Che-Kai, Appleman, Leonard J., Gartrell, Benjamin A., Hussain, Arif, Stadler, Walter M., Agarwal, Neeraj, Pachynski, Russell K., Hutson, Thomas E., Hammers, Hans J., Ryan, Christopher W., Mardekian, Jack, Borham, Azah, George, Daniel J., Harrison, Michael R.

Source: Clinical genitourinary cancer. 20(1):1-10

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100167675040.0x000001&indx=1&recIds=ETOCvdc_100167675040.0x000001